6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Substance Use Disorders: Prevention, Diagnosis, and Treatment
From early educational initiatives to sophisticated diagnostic assessments, addressing substance-related conditions requires a multilayered approach. The complexity of substance use disorders: prevention, diagnosis, and treatment involves not only identifying risk factors but also crafting interventions that are culturally relevant and accessible. Screening tools have become more refined, enhancing the accuracy of early detection in both clinical and community settings. Preventive models incorporate family dynamics, socioeconomic influences, and school-based programs to deter initiation. Once diagnosed, treatment now ranges from behavioral therapies to medication-assisted recovery, often within integrated care systems. Progress lies in the synergy between research, policy, and compassionate care delivery.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for substance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States